期刊文献+

高血糖抑制大鼠载脂蛋白M的表达和分泌

Suppression of Apolipoprotein M Expression and Secretion in Hyperglycemia Rat
原文传递
导出
摘要 目的了解高血糖对SD大鼠载脂蛋白M(apoM)表达和分泌的影响。方法于大鼠尾静脉置管,采用微量注射泵以2.5 ml/h速度连续6 h泵入25%葡萄糖注射液的方法建立生理性高血糖大鼠模型。对照组采用同样方法泵入生理盐水。Dot-blotting法检测血清apoM浓度的变化,Real-Time PCR法检测肝脏apoM mRNA的表达。采用Mann-Whitney检验进行统计分析。结果高糖组大鼠肝脏apoM mRNA的表达较对照组降低54%(P<0.01),血清apoM的浓度较对照下降32.1%,但差异无统计学意义(P>0.05)。结论高血糖可抑制大鼠载脂蛋白M的表达和分泌。 Objective To investigate the effect of glucose on the expression and secretion of apolipoprotein M(apoM) in the rats. Methods Hyperglycemia rat models were induced by 6-hour continuous infusion of 25% glucose solution through tail veins at the speed of 2.5ml per hour by microinfusion pumps. The controls were infused with saline in the same way. The concentration of apoM in the serum was assayed by Dot-blotting and the mRNA levels of apoM in the liver were measured by Real-Time PCR. Comparisons among groups were statistically analyzed by two-tailed Mann-Whitney test. A P value less than 0.05 was considered as statistically significant. Results The blood glucose and insulin levels in hyperglycemia group was 3 times higher than that in the control group. The hepatic apoM mRNA levels were significantly decreased in hyperglycemia rats compared to that in the controls(P〈0.01). The serum apoM levels of hyperglycemia rats were lower than that in the controls, but without statistic significance (P〉0.05). Conclusion The expression and secretion of apoM are down-regnlated in hyperglycemia rats.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2009年第2期240-242,245,共4页 Suzhou University Journal of Medical Science
基金 国家自然科学基金资助项目(30570752)
关键词 载脂蛋白M 高密度脂蛋白 血糖 胰岛素 动脉粥样硬化 apolipoprotein M insulin hyperglycemia high-density lipoprotein atherosclerosis
  • 相关文献

参考文献9

  • 1Richter S,Shih DQ,Pearson ER,et al.Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-lalpha:haploinsufllciency is associated with reduced serum apolipoprotein M levels[J].Diabetes,2003,52(12):2989-2995.
  • 2Xu N,Nilsson-Ehle P,Ahren B.Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse:Partial reversal by insulin[J].Biochemical Biophysical Research Communications,2006,342(4):1174-1177.
  • 3Niu N,Zhu X,Liu Y,et al.Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese[J],Diabetes Metabolism Research Review,2006,30:711-714.
  • 4姚康,葛均波,孙爱军,洪晓武,施鸿毓,黄榕翀,贾庆哲,王克强,钟翠平,曹雪涛,邹云增.高糖对人单核细胞源树突状细胞分化成熟和免疫功能的影响及其机制研究[J].中华心血管病杂志,2006,34(1):60-64. 被引量:18
  • 5Duma W,Paka L,Pillarisetti S,et al.Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells:evidence for a protective role for glucosamine in atherosclerosis[J].Cardiovascular Diabetology,2005,4:16.
  • 6Sanvaget D,Chauffeton V,Dugue-Pujol S,et al.In vitro transcriptional induction of the human apolipoprotein A-Ⅱ gene by glucose[J].Diabetes,2004,53(3):672-678,
  • 7Duan J,Dahlback B,Villout reix BO.Proposed lipocalin fold for apolipoprotein M based on bioinformatics and sitedirected mutagenesis[J].Federation of European Biochemical Societies Letters,2001,499(1-2):127-132.
  • 8Xu N,Ahren B,Jiang J,et al.Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 eells[J].Biochimica et Biophysica Acts,2006,1761(2):256-260.
  • 9Xu N,Nilsson-Ehle P,Hurtig M,et al.Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo[J].Biochemical and Biophysical Research Communications,2004,321(4):916-921.

二级参考文献12

  • 1贾庆哲,葛均波,梁春,罗育坤,黄东,王克强,陈灏珠.糖基化终产物对人单核细胞源树突状细胞清道夫受体A表达的影响及其机制的研究[J].中华心血管病杂志,2004,32(10):888-892. 被引量:9
  • 2Ross IL Atherosclerosis--an inflammatory disease. N Engl J Med,1999,340:115-126.
  • 3Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of athemsclerosis. Circ Res, 2002,91 :281-291.
  • 4Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherescleretic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res, 1998,37:799-810.
  • 5Ge J, Jia Q, Liang C, et al. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol, 2005,25:2157-2163.
  • 6Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes, 1999,48:937-942.
  • 7Wick G, Perschinka H, Millonig G. Atherescleresis as an autoimmune disease: an update. Trends Immunol, 2001,22: 665-669.
  • 8Aicher A, Heeschen C, Mohaupt M, et al. Nicotine strongly activates dendritic cell-mediated adaptive immunity : potential role for progression of atherosclerotic lesions. Circulation, 2003, 107: 604-611.
  • 9Alderman CJ, Bunyard PR, Chain BM, et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res,2002,55:806-819.
  • 10Michael B. Biochemistry and molecular cell biology of diabetic complication. Nature, 2001, 414:813-817.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部